Global Artificial Intelligence (AI) in Medical Writing Market 2025-2035

Description

List of Tables

Global Artificial Intelligence (AI) in Medical Writing Market Size, Share & Trends Analysis Report by Type (Clinical Writing, Type Writing, Scientific Writing, and Others), and by End User (Medical Devices, Pharmaceutical, Biotechnology, and Others), Forecast Period (2025-2035)

Artificial Intelligence (AI) in medical writing market was valued at $868.9 million in 2024 and is projected to reach $3,069.7 million by 2035, growing at a CAGR of 12.3% during the forecast period (2025-2035). The market for AI in medical writing is growing substantially, driven by rising demand for automation and efficiency in healthcare documentation. Advances in natural language processing (NLP) and machine learning are enhancing the speed and accuracy of medical content generation. Pharmaceutical companies, regulatory bodies, and academic institutions are leveraging artificial intelligence-based solutions to automate the reporting and submission of clinical trials under mounting pressures. Among the drivers of the market are mounting volumes of data related to health as well as the requirement for precision of documentation. AI solutions reduce the chances of errors while enhancing compliance with regulators.

Segmental Outlook

Based on the type, the market is segmented into clinical writing, typewriting, scientific writing, and others.
Based on the application, the market is segmented into medical devices, pharmaceuticals, biotechnology, and others.

The Pharmaceutical Sub-Segment is Anticipated to Hold a Considerable Share of the Global AI in Medical Writing Market

The pharmaceutical sub-segment is anticipated to capture a significant portion of the global AI in the medical writing market. The segmental growth owes to the progress and accuracy brought about by AI in medical treatments. This advancement has compelled major players in the pharmaceutical sector to concentrate on investment in efficient AI writing solutions within their firms. Numerous ones are also entering into partnerships with AI-based companies, a strategic decision that further drives the growth of the market. Pharmaceutical sub-segment leads the AI in the medical writing market, fueled by huge R&D spending, clinical trials with high data volumes, and an increasing need for faster, error-proof regulatory documents. Pharm giants are using AI to automate drug development and compliance processes, which will increase efficiency and decrease time-to-market.

Regional Outlook

The Global AI in medical writing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising expenditure in healthcare, coupled with the growing demand for efficient healthcare solutions. Additionally, the rapid technological advancements in countries such as China, Japan, South Korea, and India have been at the forefront of technological advancements in AI.

The North America Region is expected to grow at a Significant CAGR in the Global AI in the medical writing Market

The North America region is anticipated to grow at a considerable CAGR. The regional growth is attributed to the rising prevalence of chronic diseases within the country and the expanding integration of advanced technology in healthcare systems. North America, driven by the US, leads the AI in the Medical Writing market, driven by advanced tech adoption and the growing need for accurate, AI-based regulatory documentation. With pharma giants and healthcare companies adopting automation to speed up drug approvals and ease compliance, AI-based writing tools are emerging as a game-changer. As the sector demands quicker, error-free documentation, the growth path of the region remains robust, making AI an integral force in revolutionizing medical communication.

Market Players Outlook

The major companies serving the global AI medical writing market include Parexel International Corporation, IQVIA Holdings Inc., SIRO Clinpharm Pvt. Ltd., Cactus Communications Pvt. Ltd., Freyr Solutions Private Limited, and others. The market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

Recent Development

In December 2024, CANTON, Mich., TrialAssure, a global leader in AI-enabled, human-driven solutions for the pharmaceutical industry and beyond, today announced a groundbreaking addition to its TrialAssure LINK AI content creation and medical writing tool.

The Report Cover

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global AI in medical writing market. Based on the availability of data, information related to new product launches and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027587

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. AI In Medical Writing Market Sales Analysis - Type | End-User ($ Million)
1.2. Research Methodology
Primary Research Approach
Secondary Research Approach
1.3. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key AI In Medical Writing Industry Trends
- 2.2.2. Market Recommendations
- 2.2.3. Conclusion

3. Market Determinants

3.1. Market Drivers
3.2. Drivers For AI In Medical Writing Market: Impact Analysis
3.3. Market Pain Points and Challenges
3.4. Restraints For AI In Medical Writing Market: Impact Analysis
3.5. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard -AI In Medical Writing Market Revenue by Manufacturers
4.2. Key Company Analysis
- 4.2.1. Overview
- 4.2.2. Product Portfolio
- 4.2.3. Financial Analysis (Subject to Data Availability)
- 4.2.4. SWOT Analysis
- 4.2.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global AI In Medical Writing Market by Type ($ Million)

5.1. Clinical Writing
5.2. Type Writing
5.3. Scientific Writing
5.4. Others

6. Global AI In Medical Writing Market by End-User ($ Million)

6.1. Medical Devices
6.2. Pharmaceutical
6.3. Biotechnology
6.4. Others

7. Regional Analysis

7.1. North American AI In Medical Writing Market Sales Analysis - Type | End-User | Country ($ Million)
- 7.1.1. United States
- 7.1.2. Canada
7.2. European AI In Medical Writing Market Sales Analysis - Type | End-User | Country ($ Million)
- 7.2.1. UK
- 7.2.2. Germany
- 7.2.3. Italy
- 7.2.4. Spain
- 7.2.5. France
- 7.2.6. Russia
- 7.2.7. Rest of Europe
7.3. Asia-Pacific AI In Medical Writing Market Sales Analysis - Type | End-User | Country ($ Million)
- 7.3.1. China
- 7.3.2. Japan
- 7.3.3. South Korea
- 7.3.4. India
- 7.3.5. Australia & New Zealand
- 7.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And others)
- 7.3.7. Rest of Asia-Pacific
7.4. Rest of the World AI In Medical Writing Market Sales Analysis - Type | End-User | Country ($ Million)
- 7.4.1. Latin America
- 7.4.2. Middle East and Africa

8. Company Profiles

8.1. Abridge AI, Inc
8.2. Benevolent AI Limited
8.3. Cactus Communications
8.4. Cardinal Health, Inc
8.5. Certara USA, Inc.
8.6. Corti AI ApS (Corti, Inc.)
8.7. Freyr Solutions Pvt. Ltd.
8.8. Heidi Health Pty Ltd.
8.9. InClin, Inc.
8.10. Insitro, Inc
8.11. IQVIA Holdings Inc
8.12. Nabla Technologies SAS
8.13. Parexel International Corp.
8.14. ProPharma Group, LLC
8.15. Quanticate Ltd.
8.16. Renalytix AI plc
8.17. SIRO Clinpharm Pvt. Ltd.
8.18. Suki AI, Inc.
8.19. Tortus AI Ltd.
8.20. Trilogy Writing & Consulting GmbH